Quest Diagnostics Inc Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Quest Diagnostics Inc (DGX) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $2.08 billion for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2022-02-28
- Quest Diagnostics Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2020-12-31 was $609.00M, a 129.81% increase year-over-year.
- Quest Diagnostics Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2020-09-30 was $591.00M, a 161.50% increase year-over-year.
- Quest Diagnostics Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2020-06-30 was $193.00M, a 11.87% decline year-over-year.
- Quest Diagnostics Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2020-03-31 was $106.00M, a 39.77% decline year-over-year.
- Quest Diagnostics Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was $2.08B, a 38.76% increase from fiscal 2020.
- Quest Diagnostics Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was $1.50B, a 69.19% increase from fiscal 2019.
- Quest Diagnostics Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2019 was $886.00M, a 12.44% increase from fiscal 2018.
- Quest Diagnostics Inc income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2018 was $788.00M, a 4.37% decline from fiscal 2017.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $2.08B 10-K · filed 2022-02-28 | |||||||
| 2020-12-31 | $609.00M 10-K · filed 2021-02-22 | $1.20B derived: sum of 2 quarters · filed 2021-02-22 | $1.39B derived: sum of 3 quarters · filed 2021-02-22 | $1.50B 10-K · filed 2022-02-28 | ||||
| 2020-09-30 | $591.00M 10-K · filed 2021-02-22 | $784.00M derived: sum of 2 quarters · filed 2021-02-22 | $890.00M 10-Q · filed 2020-10-23 | $1.16B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2020-06-30 | $193.00M 10-K · filed 2021-02-22 | $299.00M 10-Q · filed 2020-07-24 | $564.00M derived: sum of 3 quarters · filed 2021-02-22 | $790.00M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2020-03-31 | $106.00M 10-K · filed 2021-02-22 | $371.00M derived: sum of 2 quarters · filed 2021-02-22 | $597.00M derived: sum of 3 quarters · filed 2021-02-22 | $816.00M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-12-31 | $265.00M 10-K · filed 2021-02-22 | $491.00M derived: sum of 2 quarters · filed 2021-02-22 | $710.00M derived: sum of 3 quarters · filed 2021-02-22 | $886.00M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $226.00M 10-K · filed 2021-02-22 | $445.00M derived: sum of 2 quarters · filed 2021-02-22 | $621.00M 10-Q · filed 2020-10-23 | $760.00M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $219.00M 10-K · filed 2021-02-22 | $395.00M 10-Q · filed 2020-07-24 | $534.00M derived: sum of 3 quarters · filed 2021-02-22 | $761.00M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | $176.00M 10-K · filed 2021-02-22 | $315.00M derived: sum of 2 quarters · filed 2021-02-22 | $542.00M derived: sum of 3 quarters · filed 2021-02-22 | $775.00M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-31 | $139.00M 10-K · filed 2020-02-20 | $366.00M derived: sum of 2 quarters · filed 2020-02-20 | $599.00M derived: sum of 3 quarters · filed 2020-02-20 | $788.00M 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $227.00M 10-K · filed 2020-02-20 | $460.00M derived: sum of 2 quarters · filed 2020-02-20 | $649.00M 10-Q · filed 2019-10-23 | |||||
| 2018-06-30 | $233.00M 10-K · filed 2020-02-20 | $422.00M 10-Q · filed 2019-07-24 | ||||||
| 2018-03-31 | $189.00M 10-K · filed 2020-02-20 | |||||||
| 2017-12-31 | $824.00M 10-K · filed 2020-02-20 | |||||||
| 2016-12-31 | $167.00M 10-K · filed 2017-02-22 | $372.00M derived: sum of 2 quarters · filed 2017-02-22 | $581.00M derived: sum of 3 quarters · filed 2017-02-22 | $696.00M 10-K · filed 2017-02-22 | ||||
| 2016-09-30 | $205.00M 10-K · filed 2017-02-22 | $414.00M derived: sum of 2 quarters · filed 2017-02-22 | $529.00M derived: sum of 3 quarters · filed 2017-02-22 | $729.00M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2016-06-30 | $209.00M 10-K · filed 2017-02-22 | $324.00M derived: sum of 2 quarters · filed 2017-02-22 | $524.00M derived: sum of 3 quarters · filed 2017-02-22 | $878.00M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2016-03-31 | $115.00M 10-K · filed 2017-02-22 | $315.00M derived: sum of 2 quarters · filed 2017-02-22 | $669.00M derived: sum of 3 quarters · filed 2017-02-22 | $798.00M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-12-31 | $200.00M 10-K · filed 2017-02-22 | $554.00M derived: sum of 2 quarters · filed 2017-02-22 | $683.00M derived: sum of 3 quarters · filed 2017-02-22 | $753.00M 10-K · filed 2017-02-22 | ||||
| 2015-09-30 | $354.00M 10-K · filed 2017-02-22 | $483.00M derived: sum of 2 quarters · filed 2017-02-22 | $553.00M derived: sum of 3 quarters · filed 2017-02-22 | $748.00M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-06-30 | $129.00M 10-K · filed 2017-02-22 | $199.00M derived: sum of 2 quarters · filed 2017-02-22 | $394.00M derived: sum of 3 quarters · filed 2017-02-22 | $533.00M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | $70.00M 10-K · filed 2017-02-22 | $265.00M derived: sum of 2 quarters · filed 2017-02-22 | $404.00M derived: sum of 3 quarters · filed 2017-02-22 | $546.00M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | $195.00M 10-K · filed 2016-02-26 | $334.00M derived: sum of 2 quarters · filed 2016-02-26 | $476.00M derived: sum of 3 quarters · filed 2016-02-26 | $587.00M 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | $139.00M 10-K · filed 2016-02-26 | $281.00M derived: sum of 2 quarters · filed 2016-02-26 | $392.00M 10-Q · filed 2014-10-30 | $543.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $142.00M 10-K · filed 2016-02-26 | $253.00M 10-Q · filed 2014-07-31 | $404.00M derived: sum of 3 quarters · filed 2016-02-26 | $816.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $111.00M 10-K · filed 2016-02-26 | $262.00M derived: sum of 2 quarters · filed 2016-02-26 | $674.00M derived: sum of 3 quarters · filed 2016-02-26 | $835.00M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $151.00M 10-K · filed 2015-02-24 | $563.00M derived: sum of 2 quarters · filed 2015-02-24 | $724.00M derived: sum of 3 quarters · filed 2015-02-24 | $848.00M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $412.00M 10-K · filed 2015-02-24 | $411.46M 10-Q · filed 2013-10-24 | $573.00M derived: sum of 2 quarters · filed 2015-02-24 | $697.00M 10-Q · filed 2014-10-30 | $696.61M 10-Q · filed 2013-10-24 | $847.00M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $161.00M 10-K · filed 2015-02-24 | $161.82M 10-Q · filed 2013-07-25 | $285.00M 10-Q · filed 2014-07-31 | $285.15M 10-Q · filed 2013-07-25 | $435.00M derived: sum of 3 quarters · filed 2015-02-24 | $602.00M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $124.00M 10-K · filed 2015-02-24 | $123.33M 10-Q · filed 2013-04-24 | $274.00M derived: sum of 2 quarters · filed 2015-02-24 | $441.00M derived: sum of 3 quarters · filed 2015-02-24 | $625.00M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2012-12-31 | $150.00M 10-K · filed 2014-02-18 | $149.99M 10-K · filed 2013-02-27 | $317.00M derived: sum of 2 quarters · filed 2014-02-18 | $501.00M derived: sum of 3 quarters · filed 2014-02-18 | $666.00M 10-K · filed 2015-02-24 | $666.50M 10-K · filed 2013-02-27 | ||
| 2012-09-30 | $167.00M 10-K · filed 2014-02-18 | $171.50M 10-Q · filed 2012-10-24 | $351.00M derived: sum of 2 quarters · filed 2014-02-18 | $516.51M 10-Q · filed 2013-10-24 | $526.27M 10-Q · filed 2012-10-24 | $709.61M derived: sum of 4 quarters · filed 2014-02-18 | ||
| 2012-06-30 | $184.00M 10-K · filed 2014-02-18 | $186.53M 10-Q · filed 2012-07-26 | $349.51M 10-Q · filed 2013-07-25 | $354.77M 10-Q · filed 2012-07-26 | $542.61M derived: sum of 3 quarters · filed 2014-02-18 | $721.79M derived: sum of 4 quarters · filed 2014-02-18 | ||
| 2012-03-31 | $165.00M 10-K · filed 2014-02-18 | $168.24M 10-Q · filed 2012-04-27 | $358.61M derived: sum of 2 quarters · filed 2014-02-18 | $537.79M derived: sum of 3 quarters · filed 2014-02-18 | $708.63M derived: sum of 4 quarters · filed 2014-02-18 | |||
| 2011-12-31 | $193.61M 10-K · filed 2013-02-27 | $199.34M 10-K · filed 2012-02-16 | $372.79M derived: sum of 2 quarters · filed 2013-02-27 | $543.63M derived: sum of 3 quarters · filed 2013-02-27 | $494.00M 10-K · filed 2014-02-18 | $507.23M 10-K · filed 2012-02-16 | ||
| 2011-09-30 | $179.17M 10-K · filed 2013-02-27 | $182.14M 10-Q · filed 2011-11-03 | $350.02M derived: sum of 2 quarters · filed 2013-02-27 | $307.89M 10-Q · filed 2012-10-24 | $475.82M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-06-30 | $170.85M 10-K · filed 2013-02-27 | $172.03M 10-Q · filed 2011-07-27 | $125.75M 10-Q · filed 2012-07-26 | $296.65M derived: sum of 3 quarters · filed 2013-02-27 | $504.76M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-03-31 | -$49.54M 10-K · filed 2013-02-27 | -$46.29M 10-Q · filed 2011-05-10 | $125.80M derived: sum of 2 quarters · filed 2013-02-27 | $333.92M derived: sum of 3 quarters · filed 2013-02-27 | $538.06M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2010-12-31 | $175.34M 10-K · filed 2012-02-16 | $383.46M derived: sum of 2 quarters · filed 2012-02-16 | $587.60M derived: sum of 3 quarters · filed 2012-02-16 | $744.86M 10-K · filed 2013-02-27 | $758.80M 10-K · filed 2011-02-16 | |||
| 2010-09-30 | $208.12M 10-K · filed 2012-02-16 | $412.26M derived: sum of 2 quarters · filed 2012-02-16 | $583.46M 10-Q · filed 2011-11-03 | $774.22M derived: sum of 4 quarters · filed 2012-02-16 | ||||
| 2010-06-30 | $204.14M 10-K · filed 2012-02-16 | $375.35M 10-Q · filed 2011-07-27 | $566.11M derived: sum of 3 quarters · filed 2012-02-16 | $767.20M derived: sum of 4 quarters · filed 2012-02-16 | ||||
| 2010-03-31 | $171.21M 10-K · filed 2012-02-16 | $361.96M derived: sum of 2 quarters · filed 2012-02-16 | $563.05M derived: sum of 3 quarters · filed 2012-02-16 | $761.34M derived: sum of 4 quarters · filed 2012-02-16 | ||||
| 2009-12-31 | $190.76M 10-K · filed 2011-02-16 | $391.85M derived: sum of 2 quarters · filed 2011-02-16 | $590.13M derived: sum of 3 quarters · filed 2011-02-16 | $767.46M 10-K · filed 2012-02-16 | ||||
| 2009-09-30 | $201.09M 10-K · filed 2011-02-16 | $399.37M derived: sum of 2 quarters · filed 2011-02-16 | $576.70M 10-Q · filed 2010-10-26 | $754.52M derived: sum of 4 quarters · filed 2011-02-16 | ||||
| 2009-06-30 | $198.28M 10-K · filed 2011-02-16 | $375.61M 10-Q · filed 2010-07-27 | $553.42M derived: sum of 3 quarters · filed 2011-02-16 | $721.71M derived: sum of 4 quarters · filed 2011-02-16 | ||||
| 2009-03-31 | $177.33M 10-K · filed 2011-02-16 | $355.14M derived: sum of 2 quarters · filed 2011-02-16 | $523.42M derived: sum of 3 quarters · filed 2011-02-16 | $693.47M derived: sum of 4 quarters · filed 2011-02-16 | ||||
| 2008-12-31 | $177.82M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-16 | $346.10M derived: sum of 2 quarters · filed 2011-02-16 | $516.14M derived: sum of 3 quarters · filed 2011-02-16 | $663.89M 10-K · filed 2011-02-16 | ||||
| 2008-09-30 | $168.28M 10-Q · filed 2009-10-27 | $338.32M derived: sum of 2 quarters · filed 2009-10-27 | $486.07M 10-Q · filed 2009-10-27 | |||||
| 2008-06-30 | $170.04M 10-Q · filed 2009-07-28 | $317.79M 10-Q · filed 2009-07-28 | ||||||
| 2007-12-31 | $580.34M 10-K · filed 2010-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |